STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2029 by analyst upside · 2026-08-12
OFIX
Orthofix Medical Inc.
Healthcare · Market Cap $417M · P/E 0x
ANALYST PRICE TARGET
+26.0%
implied upside to consensus target
Current Price $10.32
Consensus Target $13.0
Bull Target $14.0
Bear Target $12.0
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
2
Hold
2
Sell
0
52-Week Low $8.85
52-Week High $16.99
YTD Return -30.5%
FUNDAMENTALS
Market Cap $417M
P/E Ratio (TTM) N/A
Forward P/E 27.9x
EPS (TTM) $-1.52
PEG Ratio 48.83
Dividend Yield N/A
Revenue (TTM) $833M
Profit Margin -7.4%
52-WEEK RANGE
52-Week Low $8.85
52-Week High $16.99
Current Price $10.32
Bear Target $12.0
Bull Target $14.0
● Now $10.32 ● Target $13.0
TRADING DATA
Avg Volume 439K
YTD Return -30.5%
Analyst Count 4
Consensus Buy
Upside to Target +26.0%
Last Updated 2026-08-12

ANALYST SUMMARY

Orthofix Medical Inc. (OFIX) is currently trading at $10.32 with a Wall Street consensus price target of $13.0, implying potential upside of 26.0% over the next 12 months. 4 analysts currently cover OFIX, with a consensus rating of Buy - 60% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $14.0, while the most cautious has a target of $12.0.

OFIX operates in the Healthcare sector with a market capitalisation of $417M. The stock is down 30.5% year-to-date and is currently trading near the lower end of its 52-week range of $8.85 – $16.99.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for OFIX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity - Reiterated
Buy → Buy 2026-05-22 Building track record
Barrington Research - Reiterated
Outperform → Outperform 2026-05-22 Building track record
Stifel - Reiterated
Buy → Buy 2026-05-22 Building track record
Barrington Research - Reiterated
Outperform → Outperform 2026-04-10 Building track record
Stifel - Reiterated
Buy → Buy 2026-03-09 Building track record
Canaccord Genuity - Reiterated
Buy → Buy 2026-02-26 Building track record
Barrington Research - Reiterated
Outperform → Outperform 2026-02-25 Building track record
Barrington Research - Reiterated
Outperform → Outperform 2026-02-17 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
52
out of 100
Coverage depth
12/30
Consensus clarity
26/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →